Johannes Jacob Pieter Kastelein, Chief Scientific Officer: NewAmsterdam Pharma NAMS Planned sale · Filed 03/05

Trade details

Type: Planned sale notice
Stock: NewAmsterdam Pharma NAMS
Person: Johannes Jacob Pieter KasteleinChief Scientific Officer
Planned sale date: 26/03/02
Filed: 26/03/05

0.3% of shares outstanding to be sold

NewAmsterdam Pharma trades, last 26 weeks

What else happened in NewAmsterdam Pharma around then

Filed or reported within 30 days of the trade day · 01/31~04/01

Johannes Jacob Pieter Kastelein's recent trades

Johannes Jacob Pieter KasteleinChief Scientific Officer
Planned sale10b5-1 planNewAmsterdam Pharma
Planned sale10b5-1 plan
NewAmsterdam Pharma
NAMS
$3.5M
125,000 sh
$3.5M
Filed 08/24
Traded 08/24
Johannes Jacob Pieter KasteleinChief Scientific Officer
Sell10b5-1 planNewAmsterdam Pharma
Sell10b5-1 plan
NewAmsterdam Pharma
NAMS
$3.2M
104,467 sh
$3.2M
Filed 03/09
Traded 03/05
Johannes Jacob Pieter KasteleinChief Scientific Officer
Sell10b5-1 planNewAmsterdam Pharma
Sell10b5-1 plan
NewAmsterdam Pharma
NAMS
$3.1M
101,409 sh
$3.1M
Filed 03/09
Traded 03/09
Johannes Jacob Pieter KasteleinChief Scientific Officer
Sell10b5-1 planNewAmsterdam Pharma
Sell10b5-1 plan
NewAmsterdam Pharma
NAMS
$2.9M
94,124 sh
$2.9M
Filed 03/09
Traded 03/06
Johannes Jacob Pieter KasteleinChief Scientific Officer
SellNewAmsterdam Pharma
Sell
NewAmsterdam Pharma
NAMS
$1.1M
30,789 sh
$1.1M
Filed 02/24
Traded 02/20

Johannes Jacob Pieter Kastelein, Chief Officer — plans to sell 300,000 sh of NewAmsterdam Pharma NAMS · $9.4M · around 03/02 · 10b5-1 plan | Whalegun